NCT05053828View on ClinicalTrials.gov

Type 2 Diabetes With Antiplatelet Drugs

CompletedOBSERVATIONAL
Enrollment

173,464

Participants

Timeline

Start Date

September 20, 2021

Primary Completion Date

January 30, 2023

Study Completion Date

January 30, 2023

Conditions
Type2 DiabetesAntiplatelet DrugsMyocardial InfarctionHeart Failure
Interventions
DRUG

Antiplatelet Drug

Antiplatelet drugs and agents

Trial Locations (1)

32827

Tabula Rasa Healthcare, Orlando

All Listed Sponsors
lead

Tabula Rasa HealthCare

INDUSTRY

NCT05053828 - Type 2 Diabetes With Antiplatelet Drugs | Biotech Hunter | Biotech Hunter